Overview

Ceftobiprole in Hospital Acquired Pneumonia

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Basilea Pharmaceutica
Treatments:
Ceftazidime
Ceftobiprole
Ceftobiprole medocaril
Cephalosporins
Linezolid
Criteria
Inclusion Criteria:

- Patients suffering from nosocomial pneumonia or ventilator-associated pneumonia

- Female patients must be postmenopausal for at least 1 year, surgically sterile, or
practicing an effective method of birth control, before entry and throughout the
study, and have a negative serum or urine pregnancy test at the screening

Exclusion Criteria:

- Known or suspected hypersensitivity to any related antibiotic medications

- Any known or suspected condition or concurrent treatment that would be contraindicated
by the prescribing information

- Treatment with any investigational drug within 30 days before enrollment

- Prior enrollment to this study